Retatrutide 10mg

Retatrutide (LY-3437943) is a synthetic peptide designed as a triple agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. 

This experimental compound, developed by Eli Lilly, consists of approximately 39-40 amino acids and is primarily investigated in preclinical models for its role in metabolic signalling and energy regulation, such as studies on obesity and related pathways.

Utilised in laboratory settings to explore multi-receptor activation effects on glucose metabolism and appetite pathways, without any approved therapeutic.

Reconstituted solutions should be used within 30 days when refrigerated. 

Important Disclaimer: This product is for laboratory research purposes only and is not intended for human or animal consumption, diagnostic, therapeutic, or medicinal applications. It has not been evaluated by the TGA or any regulatory body. By purchasing, you affirm your status as a qualified researcher and agree to handle it responsibly—because even super-peptides can’t fix poor lab etiquette.